Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

American Medical Association, Jama Network Open, 4(5), p. e227657, 2022

Journal article published in 2022 by Oren Auster, Balicer Rd, Uriah Finkel, Noa Dagan, Noam Barda

, Alon Laufer, Ran D. Balicer, Shay Ben-Shachar

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by